This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Nov;9(4):104.

doi: 10.1136/ebmh.9.4.104.

Donepezil improves cognitive function and reduces decline in activities of daily living in people with severe Alzheimer's disease

John M Ringman¹

Affiliations

PMID: 17065301
DOI: 10.1136/ebmh.9.4.104

Comment

Donepezil improves cognitive function and reduces decline in activities of daily living in people with severe Alzheimer's disease

John M Ringman. Evid Based Ment Health. 2006 Nov.

. 2006 Nov;9(4):104.

doi: 10.1136/ebmh.9.4.104.

Author

John M Ringman¹

Affiliation

¹ UCLA Alzheimer's Disease Research Center, Los Angeles, CA, USA.

PMID: 17065301
DOI: 10.1136/ebmh.9.4.104

No abstract available

PubMed Disclaimer

Comment on

Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A; Severe Alzheimer's Disease Study Group. Winblad B, et al. Lancet. 2006 Apr 1;367(9516):1057-1065. doi: 10.1016/S0140-6736(06)68350-5. Lancet. 2006. PMID: 16581404 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.